Companies warn investors that DOGE’s federal cuts might hurt business
As earnings season begins, filings to the SEC point to uncertainty from the current administration as potential trouble for ...
Ozempic maker says its Australian market could be half the population
Novo Nordisk says many Australians would be willing to pay the out-of-pocket costs for its blockbuster medicines, which can ...
Devdiscourse1d
Health Headlines: Major Drug Halts, Egg Price Probe, and More
The latest health news includes Johnson & Johnson halting testing on a depression drug, USDA eliminating food safety advisory ...
Lilly's Baricitinib Delivered High Rates Of Hair Regrowth For Adolescents With Severe Alopecia Areata In Phase 3 BRAVE-AA-PEDS Study
Late-breaking results presented at AAD show 80% or more scalp hair coverage at Week 36 in 42.4% of adolescents receiving baricitinib 4 mg ...
Eli Lilly and Company (LLY): Jim Cramer Says ‘Don’t Sell’ – A Visionary Stock to Hold!
On Thursday, Jim Cramer, the host of Mad Money, discussed the recent turbulence in the stock market, pointing to the lack of ...
Eli Lilly and Company (LLY): Among The Stocks With At Least $10 Million In Insider Sales Recently
We recently compiled a list of the 10 Stocks With At Least $10 Million In Insider Sales Recently. In this article, we are ...
US judge denies injunction, restricting copies of Lilly weight-loss drug
A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...
STAT2d
The long history of the U.S. trying to control and dismantle the WHO
In fact, although never before so brutally and blatantly, the United States has bribed and bullied the WHO from the earliest ...
FMIBlog2d
Global Antidiabetic Market Poised for Robust Growth, Projected to Reach USD 298.2 Billion by 2034
The global antidiabetics market is on a strong growth trajectory, with sales projected to soar from USD 106.3 billion in 2024 to USD 298.2 billion by 2034. This substantial increase reflects a robust ...
Devdiscourse3d
Reuters Health News Summary
According to Halozyme, the new version of Keytruda infringes on its patents, the report said. USAID cuts put tuberculosis response in peril, WHO says The Trump administration's decision to pause U.S.